Annexon Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
/ 
Frequently asked questions
To buy Annexon Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Annexon Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Annexon Inc. is ANNX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Annexon Inc. has its primary listing on NASDAQ. You can trade Annexon Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Annexon Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Annexon Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Annexon Inc..